This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
Active as of 2022-05-29 |
Resource Evidence "47665" Version "14" Updated "2023-12-06 17:44:57+0000"
Profiles: ComparativeEvidence, SingleStudyEvidence
StructureDefinition Work Group: cds
url: https://fevir.net/resources/Evidence/47665
identifier: FEvIR Object Identifier: 47665
version: 1.0.0-ballot
name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Mingrone_2012_DIBASY_trial
title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2012 (DIBASY) trial
status: active
date: 2022-05-29 11:06:42+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
author: Brian S. Alper:
Code | Value[x] |
Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | ComparativeEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#ComparativeEvidence) |
Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | SingleStudyEvidence (Evidence Based Medicine on FHIR Implementation Guide Code System#SingleStudyEvidence) |
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
relatedArtifact
type: derived-from
label: data source
display: Figure 2C
citation: Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations [Journal Article]. Contributors: Francesco Rubino, David M Nathan, Robert H Eckel, Philip R Schauer, K George M M Alberti, Paul Z Zimmet, Stefano Del Prato, Linong Ji, Shaukat M Sadikot, William H Herman, Stephanie A Amiel, Lee M Kaplan, Gaspar Taroncher-Oldenburg, David E Cummings, Delegates of the 2nd Diabetes Surgery Summit. In: Diabetes care, PMID 27222544. Published June 2016. Available at: https://pubmed.ncbi.nlm.nih.gov/27222544/.
document
relatedArtifact
type: cite-as
citation: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2012 (DIBASY) trial [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47665. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47665. Computable resource at: https://fevir.net/resources/Evidence/47665.
description: Mean HbA1c at 24 months in Mingrone 2012 was 5.65% in Surgery group (n = 20) and 7.69% in Medical/Lifestyle group (n = 20), mean difference -2.04% (95% CI -2.53% to -1.55%)
variableDefinition
VariableDefinitionVariableRoleCode: population
description: 60 patients aged 30-60 years with a body-mass index of 35 kg/m(2) or more and a history of type 2 diabetes lasting at least 5 years
note: population
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#population "population")
observed: Group/46117: DIBASY Trial Enrollment Group "StudyGroup_DIBASY_Trial_Enrollment_Group"
variableDefinition
VariableDefinitionVariableRoleCode: exposure
VariableDefinitionComparatorCategory: medical treatment
description: Roux-en-Y gastric bypass vs. medical treatment
note: exposure
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#exposure "exposure")
observed: EvidenceVariable/172478: GroupAssignment: Roux-en-Y gastric bypass vs. medical treatment "GroupAssignment_Roux_en_Y_gastric_bypass_vs_medical_treatment"
variableDefinition
VariableDefinitionVariableRoleCode: outcome
description: HbA1c at 24 months
note: outcome
variableRole: Use extension:variableRoleCode instead. (EvidenceVariableRole#measuredVariable "measured variable")
observed: EvidenceVariable/173246: OutcomeVariable: HbA1c at 24 months "OutcomeVariable_HbA1c_at_24_months"
synthesisType: not applicable (StatisticSynthesisType#NotApplicable)
studyDesign: randomized assignment (Scientific Evidence Code System (SEVCO) -- EXAMPLE VERSION for EBMonFHIR Implementation Guide#SEVCO:01003)
statistic
description: mean difference -2.04% (95% CI -2.53% to -1.55%)
note: Mean HbA1c at 24 months in Mingrone 2012 was 5.65% in Surgery group (n = 20) and 7.69% in Medical/Lifestyle group (n = 20)
statisticType: Mean Difference (StatisticStatisticType#0000457)
quantity: -2.04 % (Details: UCUM code % = '%')
SampleSizes
NumberOfParticipants KnownDataCount 40 40 AttributeEstimates
Description Type Level Range 95% CI -2.53% to -1.55% Confidence interval (StatisticAttribute Estimate Type#C53324) 0.95 -2.53--1.55 %